Don B. Sanders, MD, MS Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Sanders earned his medical degree from Northwestern University and completed his residency at Children's Memorial Hospital, Chicago. He completed his fellowship at Seattle Children's Hospital and is board certified in pediatrics and pediatric pulmonology.
UW Health Clinics
Regional Specialty Clinics
UW School of Medicine and Public Health
|Department of Pediatrics|
Professional Certifications and Education
Pediatric Pulmonology, Seattle Children's Hospital and Regional Medical Center, Seattle, WA
Children's Memorial Hospital, Chicago, IL
Northwestern University, Feinberg School of Medicine, Chicago, IL, 2003
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Programs & Conditions
Cogen J Emerson J Sanders DB Ren C Schechter MS Gibson RL Morgan W Rosenfeld M .
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Pediatr Pulmonol. 2015 Jun 9;
[PubMed ID: 26061914]
Ren CL Fink AK Petren K Borowitz DS McColley SA Sanders DB Rosenfeld M Marshall BC .
Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening. Pediatrics. 2015 Jun;135(6):e1386-92
[PubMed ID: 25963008]
Heltshe SL Goss CH Thompson V Sagel SD Sanders DB Marshall BC Flume PA .
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis. Thorax. 2015 Apr 24;
[PubMed ID: 25911223]
Sanders DB .
Phenotypes that matter: Pseudomonas aeruginosa and progression of cystic fibrosis lung disease. Am J Respir Crit Care Med. 2014 Aug 1;190(3):245-6
[PubMed ID: 25084257]
Sanders DB Li Z Laxova A Rock MJ Levy H Collins J Ferec C Farrell PM .
Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc. 2014 Jan;11(1):63-72
[PubMed ID: 24261460]
Li Z Sanders DB Rock MJ Kosorok MR Collins J Green CG Brody AS Farrell PM .
Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatr Pulmonol. 2012 Jul;47(7):635-40
[PubMed ID: 22162514]
Sanders DB Li Z Rock MJ Brody AS Farrell PM .
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun;47(6):567-73
[PubMed ID: 22170734]
Sanders DB Lai HJ Rock MJ Farrell PM .
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies. J Cyst Fibros. 2012 Mar;11(2):150-3
[PubMed ID: 22104951]
Sanders DB Li Z Brody AS Farrell PM .
Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis. Am J Respir Crit Care Med. 2011 Oct 1;184(7):816-21
[PubMed ID: 21737586]
Sanders DB Bittner RC Rosenfeld M Redding GJ Goss CH .
Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011 Apr;46(4):393-400
[PubMed ID: 20967845]
Sanders DB Bittner RC Rosenfeld M Hoffman LR Redding GJ Goss CH .
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med. 2010 Sep 1;182(5):627-32
[PubMed ID: 20463179]
Sanders DB Hoffman LR Emerson J Gibson RL Rosenfeld M Redding GJ Goss CH .
Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol. 2010 Feb;45(2):127-34
[PubMed ID: 20054859]